Xcout IntelSign inSubscribe

Idorsia Pharmaceuticals Ltd competitors & alternatives

Pharmaceuticals, BiotechSwitzerland

The 12 closest competitors and alternatives to Idorsia Pharmaceuticals Ltd among pharmaceuticals, biotech companies — ranked by similarity to what Idorsia Pharmaceuticals Ltd actually does, not by market-cap band.

12Competitors listed

Subscribe to see Idorsia Pharmaceuticals Ltd’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

About Idorsia Pharmaceuticals Ltd

Idorsia Pharmaceuticals Ltd is a biopharmaceutical company that conducts drug discovery, clinical development, and commercial operations to provide transformative treatments for patients. The company focuses on researching and developing therapeutic products and vaccines targeting conditions such as insomnia, hypertension, and Fabry disease.

Idorsia Pharmaceuticals Ltd at a glance

Idorsia Pharmaceuticals Ltd is a pharmaceuticals, biotech company headquartered in Switzerland. Xcout tracks 11 named people at Idorsia Pharmaceuticals Ltd, including Jean-Paul Clozel (Chairman of the Board, interim CEO).

Idorsia Pharmaceuticals Ltd leadership

  • Jean-Paul ClozelChairman of the Board, interim CEO
  • Roland WandelerChief Executive Officer
  • Arno GroenewoudExecutive Vice President, Chief Financial Officer
  • Julien GanderExecutive Vice President, Chief Legal & Corporate Development Officer
  • Martine ClozelExecutive Vice President, Chief Scientific Officer & Head of Research
  • Shal JacobovitzPresident of Idorsia US

5 more named people on record for Idorsia Pharmaceuticals Ltd, with roles, board committees and tenure — see the full roster →

Top 12 Idorsia Pharmaceuticals Ltd competitors

Ranked by semantic similarity — how close each company is to Idorsia Pharmaceuticals Ltd by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.

Vanda Pharmaceuticals Inc.VNDA · PharmaceuticalsWashington, United States
68% matchPublic

Pharmaceuticals

Vanda Pharmaceuticals Inc. is a biopharmaceutical company dedicated to developing and commercializing therapeutic solutions that address critical unmet medical needs. The company currently offers two approved treatments: HETLIOZ, prescribed for non-24-hour sleep-wake disorders, and Fanapt oral tablets, used in the management of schizophrenia. Vanda maintains an active and diverse development pipeline, exploring new applications for its existing therapies and advancing a range of novel compounds. This includes expanding HETLIOZ (tasimelteon) to potentially treat conditions such as jet lag disorder, Smith-Magenis Syndrome, pediatric Non-24, autism spectrum disorder, and delayed sleep phase disorder. Fanapt (iloperidone) is being investigated for bipolar disorder, alongside the creation of a long-acting injectable formulation for schizophrenia. Other promising candidates in development include: Tradipitant (VLY-686): A small molecule neurokinin-1 receptor (NK-1R) antagonist for atopic dermatitis, gastroparesis, and motion sickness. VTR-297: A small molecule histone deacetylase inhibitor, primarily for hematologic malignancies but with broader oncology potential. VQW-765: A small molecule nicotinic acetylcholine receptor partial agonist targeting psychiatric disorders. A portfolio of cystic fibrosis transmembrane conductance regulator (CFTR) activators and inhibitors aimed at dry eye and ocular inflammation. BPO-27: For secretory diarrhea disorders, including cholera. VHX-896: The active metabolite of iloperidone. Vanda Pharmaceuticals Inc. markets its products in the United States, Europe, and Israel. The company was established in 2002 and is headquartered in Washington, D.C.

Market cap$316.3M
Employees368
Vanda Pharmaceuticals Inc. competitors & alternatives →

Analyze another company

Search any company we track to see its competitive set.

Or describe a company

Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.

See the full profile of Idorsia Pharmaceuticals Ltd and its market

Funding, investors, tech stack, hiring signals, leadership and corporate events — for Idorsia Pharmaceuticals Ltdand every competitor above — in one live dashboard.

Subscribe to Xcout Intel →